NCT03048383View on ClinicalTrials.gov

Comparison of Three Botulinum Neuromodulators for Management of Facial Synkinesis

PHASE4CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Facial Nerve InjuriesFacial Paresis Associated With Facial Nerve DysfunctionFacial AsymmetrySynkinesis
Interventions
DRUG

OnabotulinumtoxinA Injectable Product

Administered to treat facial synkinesis

DRUG

AbobotulinumtoxinA Injectable Product

Administered to treat facial synkinesis

DRUG

Incobotulinumtoxin A Injectable Product

Administered to treat facial synkinesis

All Listed Sponsors
lead

University of Utah

OTHER

NCT03048383 - Comparison of Three Botulinum Neuromodulators for Management of Facial Synkinesis | Biotech Hunter | Biotech Hunter